Last edition
News about "saRNA Flu Vaccines"
Apriori Bio, A*STAR IDL Partner to Develop Next-Gen AI-Designed saRNA Flu Vaccines
Apriori Bio, a Flagship Pioneering company focused on creating variant-resilient vaccines, has announced a strategic research partnership with the ASTAR Infectious Diseases Labs (ASTAR IDL) to co-develop next-generation self-amplifying RNA (saRNA) vaccines for seasonal and pandemic influenza.
SaRNA Flu Vaccines | 19/11/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members